What Is the Future of the Oral Cancer Treatment Market? Growth Forecasts & Insights to 2032 Global oral cancer treatment market is undergoing significant transformation as healthcare systems adopt more advanced therapeutic approaches, precision oncology, and early detection strategies. Valued at USD 2,410 million in 2024, the market is projected to increase from USD 2,518 million in 2025 to USD 3,220 million by 2032, reflecting a 4.3% CAGR. Growth is strongly driven by rising cancer prevalence, expanding geriatric populations, technological progress in oncology, and a robust shift toward targeted and immunotherapy-based treatment pathways. Access the complete report https://www.24lifesciences.com/oral-cancer-treatment-market-9564

Sex Cord Gonadal Stromal Tumor Treatment Market to Reach USD 104 Million by 2031 Global sex cord gonadal stromal tumor (SCGST) treatment market is witnessing measured yet meaningful growth as healthcare systems place increasing emphasis on rare cancer management, personalized oncology, and surgical excellence. Valued at approximately USD 75 million in 2024, the market is projected to reach USD 104 million by 2031, expanding at a compound annual growth rate (CAGR) of 4.8% during the forecast period. Rising diagnostic precision, expanding access to specialized oncology care, and continued research into targeted therapies are shaping the future of this niche but critical cancer treatment segment. Access the market report https://www.24lifesciences.com/sex-cord-gonadal-stromal-tumor-treatment-market-9089